Start |  Archive |  Services |  About Us |  Contact

Search News

FDA Safety Official Testifies COX-2 Inhibitors Have Cardiovascular Risks Similar to Smoking at Advisory Committee Meeting

COX-2 inhibitors increase risk for cardiovascular events at about the same rate as cigarette smoking, hypertension and diabetes, http://www... click link for more info.

Continue to FDA Safety Official Testifies COX-2 Inhibitors Have Cardiovascular Risks Similar to Smoking at Advisory Committee Meeting on Medical News Today.

Your health is news!

Medical buzz is a member of the HarWester Network.